These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Enhanced production and activation of progelatinase A mediated by membrane-type 1 matrix metalloproteinase in human papillary thyroid carcinomas. Nakamura H, Ueno H, Yamashita K, Shimada T, Yamamoto E, Noguchi M, Fujimoto N, Sato H, Seiki M, Okada Y. Cancer Res; 1999 Jan 15; 59(2):467-73. PubMed ID: 9927064 [Abstract] [Full Text] [Related]
6. Activation of pro-MMP-2 mediated by MT1-MMP in human salivary gland carcinomas: possible regulation of pro-MMP-2 activation by TIMP-2. Kayano K, Shimada T, Shinomiya T, Nakai S, Hisa Y, Aoki T, Seiki M, Okada Y. J Pathol; 2004 Apr 15; 202(4):403-11. PubMed ID: 15095267 [Abstract] [Full Text] [Related]
7. Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human invasive breast carcinomas. Ueno H, Nakamura H, Inoue M, Imai K, Noguchi M, Sato H, Seiki M, Okada Y. Cancer Res; 1997 May 15; 57(10):2055-60. PubMed ID: 9158005 [Abstract] [Full Text] [Related]
8. Presence of active gelatinases in endometrial carcinoma and correlation of matrix metalloproteinase expression with increasing tumor grade and invasion. Di Nezza LA, Misajon A, Zhang J, Jobling T, Quinn MA, Ostör AG, Nie G, Lopata A, Salamonsen LA. Cancer; 2002 Mar 01; 94(5):1466-75. PubMed ID: 11920503 [Abstract] [Full Text] [Related]
11. Effects of 17beta-estradiol on the expression of membrane type 1 matrix metalloproteinase (MT1-MMP) and MMP-2 in human osteoblastic MG-63 cell cultures. Liao EY, Luo XH, Deng XG, Wu XP. J Endocrinol Invest; 2001 Dec 01; 24(11):876-81. PubMed ID: 11817712 [Abstract] [Full Text] [Related]
13. Differences between scirrhous and non-scirrhous human gastric carcinomas from the aspect of proMMP-2 activation regulated by TIMP-3. Yokoyama T, Nakamura H, Otani Y, Kubota T, Fujimoto N, Seiki M, Kitajima M, Okada Y. Clin Exp Metastasis; 2004 Dec 01; 21(3):223-33. PubMed ID: 15387372 [Abstract] [Full Text] [Related]
14. Membrane-type 1 matrix metalloproteinase-mediated progelatinase A activation in non-tumorigenic and tumorigenic human keratinocytes. Baumann P, Zigrino P, Mauch C, Breitkreutz D, Nischt R. Br J Cancer; 2000 Nov 01; 83(10):1387-93. PubMed ID: 11044366 [Abstract] [Full Text] [Related]
16. Differential expression and origin of membrane-type 1 and 2 matrix metalloproteinases (MT-MMPs) in association with MMP2 activation in injured human livers. Théret N, Musso O, L'Helgoualc'h A, Campion JP, Clément B. Am J Pathol; 1998 Sep 01; 153(3):945-54. PubMed ID: 9736043 [Abstract] [Full Text] [Related]
17. Enhancement of membrane-type 1-matrix metalloproteinase (MT1-MMP) production and sequential activation of progelatinase A on human squamous carcinoma cells co-cultured with human dermal fibroblasts. Sato T, Iwai M, Sakai T, Sato H, Seiki M, Mori Y, Ito A. Br J Cancer; 1999 Jun 01; 80(8):1137-43. PubMed ID: 10376963 [Abstract] [Full Text] [Related]
18. Calmodulin antagonists increase the expression of membrane-type-1 matrix metalloproteinase in human uterine cervical fibroblasts. Ito A, Yamada M, Sato T, Sanekata K, Sato H, Seiki M, Nagase H, Mori Y. Eur J Biochem; 1998 Jan 15; 251(1-2):353-8. PubMed ID: 9492304 [Abstract] [Full Text] [Related]
20. Expression and tissue localization of membrane-type 1, 2, and 3 matrix metalloproteinases in human astrocytic tumors. Nakada M, Nakamura H, Ikeda E, Fujimoto N, Yamashita J, Sato H, Seiki M, Okada Y. Am J Pathol; 1999 Feb 15; 154(2):417-28. PubMed ID: 10027400 [Abstract] [Full Text] [Related] Page: [Next] [New Search]